Diaryltriazenes as antibacterial agents against methicillin resistant Staphylococcus aureus (MRSA) and Mycobacterium smegmatis. (2017)
Attributed to:
Development and validation of new reagents and assays to exploit the final steps of peptidoglycan construction
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ejmech.2016.12.060
PubMed Identifier: 28063354
Publication URI: http://europepmc.org/abstract/MED/28063354
Type: Journal Article/Review
Volume: 127
Parent Publication: European journal of medicinal chemistry
ISSN: 0223-5234